vTv Therapeutics (VTVT) Non-Current Assets (2014 - 2026)

vTv Therapeutics has disclosed Non-Current Assets across 13 years of filings, most recently posting $5000.0 for Q1 2026.

• Non-Current Assets for Q1 2026 came in at $5000.0, down 95.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $123000.0 (down 83.1% YoY), and the FY2025 annual result was $6000.0, down 96.08% from the prior year.
• Non-Current Assets came in at $5000.0 for Q1 2026 at vTv Therapeutics, down from $6000.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $8.5 million in Q2 2023 to a low of $5000.0 in Q1 2026.
• The 5-year median for Non-Current Assets is $311000.0 (2024), against an average of $2.9 million.
• Across the five-year window, Non-Current Assets jumped 33.04% in 2023 and plunged 96.96% in 2024, its largest moves.
• vTv Therapeutics' Non-Current Assets stood at $6.1 million in 2022, then plunged by 94.12% to $361000.0 in 2023, then plunged by 57.62% to $153000.0 in 2024, then tumbled by 96.08% to $6000.0 in 2025, then dropped by 16.67% to $5000.0 in 2026.
• The last three Non-Current Assets figures came in at $5000.0 (Q1 2026), $6000.0 (Q4 2025), and $38000.0 (Q3 2025), per Business Quant data.